cd4 biolegend pe cy5 gk1 5 cd8 biolegend pe cy7 Search Results


95
ATCC anti cd4
Anti Cd4, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cd4/product/ATCC
Average 95 stars, based on 1 article reviews
anti cd4 - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier

95
Miltenyi Biotec blue c63d9 mouse cell signaling 9066s tox apc rea473 mouse miltenyi biotec 130 118 335 cd4 af700 gk1 5 mouse biolegend
Blue C63d9 Mouse Cell Signaling 9066s Tox Apc Rea473 Mouse Miltenyi Biotec 130 118 335 Cd4 Af700 Gk1 5 Mouse Biolegend, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/blue c63d9 mouse cell signaling 9066s tox apc rea473 mouse miltenyi biotec 130 118 335 cd4 af700 gk1 5 mouse biolegend/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
blue c63d9 mouse cell signaling 9066s tox apc rea473 mouse miltenyi biotec 130 118 335 cd4 af700 gk1 5 mouse biolegend - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier

94
Thermo Fisher 140317 percp cy5 5 cd45 30 f11 ebioscience 45 0451 82 apc cd4 gk15 biolegend 100412 pe cy7 cd8
140317 Percp Cy5 5 Cd45 30 F11 Ebioscience 45 0451 82 Apc Cd4 Gk15 Biolegend 100412 Pe Cy7 Cd8, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/140317 percp cy5 5 cd45 30 f11 ebioscience 45 0451 82 apc cd4 gk15 biolegend 100412 pe cy7 cd8/product/Thermo Fisher
Average 94 stars, based on 1 article reviews
140317 percp cy5 5 cd45 30 f11 ebioscience 45 0451 82 apc cd4 gk15 biolegend 100412 pe cy7 cd8 - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

91
Revvity anti mouse
Anti Mouse, supplied by Revvity, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti mouse/product/Revvity
Average 91 stars, based on 1 article reviews
anti mouse - by Bioz Stars, 2026-05
91/100 stars
  Buy from Supplier

90
Becton Dickinson cd4 (gk1.5
Clonal potential of FL ILC progenitors. Single-cell potential of the indicated ILC progenitors sorted from Zbtb16 EGFPCre Tcf7 mCherry Rorc Thy1.1 E14-E16 FLs onto OP9 stromal cells. Pie charts represent the frequency of single ILC1 (NK1.1 + ICOS − α4β7 − ), ILC2 (NK1.1 − ICOS + α4β7 − ), and ILC3/LTi 0 (NK1.1 − ICOS +/− α4β7 + <t>CD4</t> − ); two or more ILC subsets (multi); LTi 4 (NK1.1 − ICOS +/− α4β7 + CD4 + ); and mixed ILC1/2/3/LTi 0 and LTi 4 (mixILC/LTi). Data are pooled from >20 independent experiments. P values for pie charts were calculated using Chi-Square Test for Independence followed by post-hoc analysis with Bonferroni correction; comparisons were made against the Flt3 + αLP (black), ILCP (blue), and LTiP (orange).
Cd4 (Gk1.5, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd4 (gk1.5/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
cd4 (gk1.5 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

98
Revvity percp cy5 5 cd4
Effect of CR on the population of tumor-infiltrating lymphocytes (TILs). ( A ) Representative dot plots depicting (upper panels) or percentages (lower panel) of TILs expressing CD3 and CD45. B16-OVA-inoculated mice were treated with/without anti-PD-1 antibody (0.2 mg/mouse i.p.) at days 3, 6, and 9 from day 0. ( B ) Representative dot plots depicting (upper panels) or percentages (lower panel) of cells expressing <t>CD4</t> and CD8 in the gated CD3 + CD45 + TILs. ( C ) Representative histograms representing surface expression (upper panels) or median fluorescence intensity (MFI) values (lower panel) of CD44 on CD3 + CD8 + CD45 + TILs derived from B16-OVA-inoculated mice. Each plot represents the mean ± SEM ( n = 4); indicated p values were obtained from a statistical comparison; one-way ANOVA with Bonferroni’s multiple comparisons correction.
Percp Cy5 5 Cd4, supplied by Revvity, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/percp cy5 5 cd4/product/Revvity
Average 98 stars, based on 1 article reviews
percp cy5 5 cd4 - by Bioz Stars, 2026-05
98/100 stars
  Buy from Supplier

90
Becton Dickinson cd4 fitc (clone gk1.5)
Effect of CR on the population of tumor-infiltrating lymphocytes (TILs). ( A ) Representative dot plots depicting (upper panels) or percentages (lower panel) of TILs expressing CD3 and CD45. B16-OVA-inoculated mice were treated with/without anti-PD-1 antibody (0.2 mg/mouse i.p.) at days 3, 6, and 9 from day 0. ( B ) Representative dot plots depicting (upper panels) or percentages (lower panel) of cells expressing <t>CD4</t> and CD8 in the gated CD3 + CD45 + TILs. ( C ) Representative histograms representing surface expression (upper panels) or median fluorescence intensity (MFI) values (lower panel) of CD44 on CD3 + CD8 + CD45 + TILs derived from B16-OVA-inoculated mice. Each plot represents the mean ± SEM ( n = 4); indicated p values were obtained from a statistical comparison; one-way ANOVA with Bonferroni’s multiple comparisons correction.
Cd4 Fitc (Clone Gk1.5), supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd4 fitc (clone gk1.5)/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
cd4 fitc (clone gk1.5) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

92
Revvity anti mouse cd4 antibody
T-MSCs inhibit DC-mediated T cell proliferation and differentiation of the <t>CD4</t> + T cell subset. (a) T cells were isolated from mouse spleens (BALB/c, 8-week-old, female) using MACS. (b) T cells were cocultured with mature DCs in the presence or absence of T-MSCs, and differentiation into CD4 + T cell subsets was induced using anti-CD3 and anti-CD28 antibodies. T cell numbers were increased upon coculturing with mature DCs. In the presence of T-MSCs, however, T cell proliferation was inhibited by 80%. (c) Differentiation into Th1, Th2, and Th17 cells also was decreased upon addition of T-MSCs.
Anti Mouse Cd4 Antibody, supplied by Revvity, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti mouse cd4 antibody/product/Revvity
Average 92 stars, based on 1 article reviews
anti mouse cd4 antibody - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier

90
Becton Dickinson cd4 bv785 (gk1.5)
External beam radiation primes B78 tumor-bearing mice for BEMPEG treatment by increasing CD122 expression on CD8+ and <t>CD4+</t> <t>T-helper</t> <t>cells</t> in the spleen; RT+BEMPEG increases the number of TILs in the B78 melanoma model. (A) Immune cell profile in the spleen 5 days after RT showing CD4+ T helpers/CD45+, CD4+ CD122+ T helpers/CD4+ T helpers, and CD122 MFI on CD4+ T helpers. (B) Immune cell profile in the spleen 5 days after RT showing CD8+/CD45+, CD8+ CD122+/CD8+, and CD122 MFI on CD8+T cells. A separate independent experiment (with a smaller sample size) demonstrated similar trends as the data presented in (A, B) (analyses here done by unpaired t-test). (C) The combined results from two independent flow experiments (n=5 per group, per experiment) showing the number of TILs as a ratio of live cells (or as a ratio to T regulatory cells for the last two panels) in the tumor following treatment with buffer (black), RT alone (blue), BEMPEG alone (pink), or RT+BEMPEG (purple) on day 14 after treatment began. Each symbol represents the TIL or splenic immune cell profile from one mouse (analyses done by one-way ANOVA). P values calculated using one-way ANOVA with Tukey’s multiple comparison tests. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001. For comparisons where there is no p value shown, the p value was not significant. ANOVA, analysis of variance; BEMPEG, bempegaldesleukin; RT, radiation therapy; TIL, tumor-infiltrating lymphocyte.
Cd4 Bv785 (Gk1.5), supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd4 bv785 (gk1.5)/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
cd4 bv785 (gk1.5) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

97
Revvity anti cd4 apc
External beam radiation primes B78 tumor-bearing mice for BEMPEG treatment by increasing CD122 expression on CD8+ and <t>CD4+</t> <t>T-helper</t> <t>cells</t> in the spleen; RT+BEMPEG increases the number of TILs in the B78 melanoma model. (A) Immune cell profile in the spleen 5 days after RT showing CD4+ T helpers/CD45+, CD4+ CD122+ T helpers/CD4+ T helpers, and CD122 MFI on CD4+ T helpers. (B) Immune cell profile in the spleen 5 days after RT showing CD8+/CD45+, CD8+ CD122+/CD8+, and CD122 MFI on CD8+T cells. A separate independent experiment (with a smaller sample size) demonstrated similar trends as the data presented in (A, B) (analyses here done by unpaired t-test). (C) The combined results from two independent flow experiments (n=5 per group, per experiment) showing the number of TILs as a ratio of live cells (or as a ratio to T regulatory cells for the last two panels) in the tumor following treatment with buffer (black), RT alone (blue), BEMPEG alone (pink), or RT+BEMPEG (purple) on day 14 after treatment began. Each symbol represents the TIL or splenic immune cell profile from one mouse (analyses done by one-way ANOVA). P values calculated using one-way ANOVA with Tukey’s multiple comparison tests. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001. For comparisons where there is no p value shown, the p value was not significant. ANOVA, analysis of variance; BEMPEG, bempegaldesleukin; RT, radiation therapy; TIL, tumor-infiltrating lymphocyte.
Anti Cd4 Apc, supplied by Revvity, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cd4 apc/product/Revvity
Average 97 stars, based on 1 article reviews
anti cd4 apc - by Bioz Stars, 2026-05
97/100 stars
  Buy from Supplier

96
Bio X Cell anti cd4
External beam radiation primes B78 tumor-bearing mice for BEMPEG treatment by increasing CD122 expression on CD8+ and <t>CD4+</t> <t>T-helper</t> <t>cells</t> in the spleen; RT+BEMPEG increases the number of TILs in the B78 melanoma model. (A) Immune cell profile in the spleen 5 days after RT showing CD4+ T helpers/CD45+, CD4+ CD122+ T helpers/CD4+ T helpers, and CD122 MFI on CD4+ T helpers. (B) Immune cell profile in the spleen 5 days after RT showing CD8+/CD45+, CD8+ CD122+/CD8+, and CD122 MFI on CD8+T cells. A separate independent experiment (with a smaller sample size) demonstrated similar trends as the data presented in (A, B) (analyses here done by unpaired t-test). (C) The combined results from two independent flow experiments (n=5 per group, per experiment) showing the number of TILs as a ratio of live cells (or as a ratio to T regulatory cells for the last two panels) in the tumor following treatment with buffer (black), RT alone (blue), BEMPEG alone (pink), or RT+BEMPEG (purple) on day 14 after treatment began. Each symbol represents the TIL or splenic immune cell profile from one mouse (analyses done by one-way ANOVA). P values calculated using one-way ANOVA with Tukey’s multiple comparison tests. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001. For comparisons where there is no p value shown, the p value was not significant. ANOVA, analysis of variance; BEMPEG, bempegaldesleukin; RT, radiation therapy; TIL, tumor-infiltrating lymphocyte.
Anti Cd4, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cd4/product/Bio X Cell
Average 96 stars, based on 1 article reviews
anti cd4 - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

90
Becton Dickinson cd4-buv496 gk1.5
External beam radiation primes B78 tumor-bearing mice for BEMPEG treatment by increasing CD122 expression on CD8+ and <t>CD4+</t> <t>T-helper</t> <t>cells</t> in the spleen; RT+BEMPEG increases the number of TILs in the B78 melanoma model. (A) Immune cell profile in the spleen 5 days after RT showing CD4+ T helpers/CD45+, CD4+ CD122+ T helpers/CD4+ T helpers, and CD122 MFI on CD4+ T helpers. (B) Immune cell profile in the spleen 5 days after RT showing CD8+/CD45+, CD8+ CD122+/CD8+, and CD122 MFI on CD8+T cells. A separate independent experiment (with a smaller sample size) demonstrated similar trends as the data presented in (A, B) (analyses here done by unpaired t-test). (C) The combined results from two independent flow experiments (n=5 per group, per experiment) showing the number of TILs as a ratio of live cells (or as a ratio to T regulatory cells for the last two panels) in the tumor following treatment with buffer (black), RT alone (blue), BEMPEG alone (pink), or RT+BEMPEG (purple) on day 14 after treatment began. Each symbol represents the TIL or splenic immune cell profile from one mouse (analyses done by one-way ANOVA). P values calculated using one-way ANOVA with Tukey’s multiple comparison tests. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001. For comparisons where there is no p value shown, the p value was not significant. ANOVA, analysis of variance; BEMPEG, bempegaldesleukin; RT, radiation therapy; TIL, tumor-infiltrating lymphocyte.
Cd4 Buv496 Gk1.5, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd4-buv496 gk1.5/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
cd4-buv496 gk1.5 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Clonal potential of FL ILC progenitors. Single-cell potential of the indicated ILC progenitors sorted from Zbtb16 EGFPCre Tcf7 mCherry Rorc Thy1.1 E14-E16 FLs onto OP9 stromal cells. Pie charts represent the frequency of single ILC1 (NK1.1 + ICOS − α4β7 − ), ILC2 (NK1.1 − ICOS + α4β7 − ), and ILC3/LTi 0 (NK1.1 − ICOS +/− α4β7 + CD4 − ); two or more ILC subsets (multi); LTi 4 (NK1.1 − ICOS +/− α4β7 + CD4 + ); and mixed ILC1/2/3/LTi 0 and LTi 4 (mixILC/LTi). Data are pooled from >20 independent experiments. P values for pie charts were calculated using Chi-Square Test for Independence followed by post-hoc analysis with Bonferroni correction; comparisons were made against the Flt3 + αLP (black), ILCP (blue), and LTiP (orange).

Journal: The Journal of Experimental Medicine

Article Title: Multi-transcription factor reporter mice delineate early precursors to the ILC and LTi lineages

doi: 10.1084/jem.20200487

Figure Lengend Snippet: Clonal potential of FL ILC progenitors. Single-cell potential of the indicated ILC progenitors sorted from Zbtb16 EGFPCre Tcf7 mCherry Rorc Thy1.1 E14-E16 FLs onto OP9 stromal cells. Pie charts represent the frequency of single ILC1 (NK1.1 + ICOS − α4β7 − ), ILC2 (NK1.1 − ICOS + α4β7 − ), and ILC3/LTi 0 (NK1.1 − ICOS +/− α4β7 + CD4 − ); two or more ILC subsets (multi); LTi 4 (NK1.1 − ICOS +/− α4β7 + CD4 + ); and mixed ILC1/2/3/LTi 0 and LTi 4 (mixILC/LTi). Data are pooled from >20 independent experiments. P values for pie charts were calculated using Chi-Square Test for Independence followed by post-hoc analysis with Bonferroni correction; comparisons were made against the Flt3 + αLP (black), ILCP (blue), and LTiP (orange).

Article Snippet: The following fluorochrome- or biotin-conjugated antibodies were used: α4β7 (DATK32), CCR6 (29-2L17), CD11c (N418), CD19 (6D5), CD90.2 (Thy-1.2; 53–2.1), CD127 (IL-7Rα; A7R34), CXCR5 (L138D7), GR-1 (RB6-8C5), ICOS (C398.4A), PD-1 (29F.1A12), Ter119 (TER-119), mouse IgG1 κ-chain (MG1-45), mouse IgG2a κ-chain (MG2a-53), and rat IgG2b κ-chain (RTK45-30; all from BioLegend); B220 (RA3-6B2), CD3ε (145-2C11), CD4 (GK1.5), CD8α (53–6.7), CD11b (M1/70), Flt3 (A2F10.1), NK1.1 (PK136), TCRβ (H57-597), Thy1.1 (OX-7), RORγt (Q31-378), and PLZF (R17-809; all from BD Biosciences); TCF1 (Cell Signaling Technologies); and polyclonal goat α-Rb IgG (Abcam).

Techniques:

Identification of Rorc expression in the FL αLP. (A) Representative flow cytometry plot of αLP from Zbtb16 EGFPCre Tcf7 mCherry Rorc Thy1.1 E15 FL ( n = 7). Adjacent plot reflects population frequencies. (B) Representative histogram plot of ID2-EYFP expression in the indicated ILC progenitors from Zbtb16 EGFPCre Tcf7 mCherry Rorc Thy1.1 ID2 EYFP E15 FL ( n = 6). Associated plots reflect population MFI. (C) MFI of Rorc -Thy1.1, CCR6, IL-7Rα, and PD-1 on Rorc + αLP, iLTiP, and LTiP from Zbtb16 EGFPCre Tcf7 mCherry Rorc Thy1.1 E15 FL ( n = 8). (D) Quantification of Flt3 − Rorc − αLP, Rorc + αLP, iLTiP, and LTiP from Zbtb16 EGFPCre Tcf7 mCherry Rorc Thy1.1 FL at E11, E13, and E15. (E) Representative flow plots and histograms of bulk cultured Flt3 − Rorc − αLP, Rorc + αLP, iLTiP, and LTiP from Zbtb16 EGFPCre Tcf7 mCherry Rorc Thy1.1 E15 FL cultured for 2 d on OP9 stromal cells ( n = 3). Adjacent plot reflects CD4 + frequency among Rorc + Tcf7 + cells. (F) Single-cell potential of the indicated αLP precursors sorted from Zbtb16 EGFPCre Tcf7 mCherry Rorc Thy1.1 E15 FL onto OP9 stromal cells. (G) Hierarchical clustering dendrogram of ILC progenitor clonal potential on OP9 stromal cells calculated from Pearson correlation. For plots, each symbol represents an individual FL; data are presented as mean ± SEM; and P values were determined by one-way ANOVA with Tukey’s multiple comparisons test. P values for pie charts were calculated using Chi-Square Test for Independence followed by post-hoc analysis with Bonferroni correction; comparisons were made against the Flt3 + Rorc − αLP (black). Data are pooled from at least two independent experiments. **, P < 0.01; ***, P < 0.001; ****, P < 0.0001.

Journal: The Journal of Experimental Medicine

Article Title: Multi-transcription factor reporter mice delineate early precursors to the ILC and LTi lineages

doi: 10.1084/jem.20200487

Figure Lengend Snippet: Identification of Rorc expression in the FL αLP. (A) Representative flow cytometry plot of αLP from Zbtb16 EGFPCre Tcf7 mCherry Rorc Thy1.1 E15 FL ( n = 7). Adjacent plot reflects population frequencies. (B) Representative histogram plot of ID2-EYFP expression in the indicated ILC progenitors from Zbtb16 EGFPCre Tcf7 mCherry Rorc Thy1.1 ID2 EYFP E15 FL ( n = 6). Associated plots reflect population MFI. (C) MFI of Rorc -Thy1.1, CCR6, IL-7Rα, and PD-1 on Rorc + αLP, iLTiP, and LTiP from Zbtb16 EGFPCre Tcf7 mCherry Rorc Thy1.1 E15 FL ( n = 8). (D) Quantification of Flt3 − Rorc − αLP, Rorc + αLP, iLTiP, and LTiP from Zbtb16 EGFPCre Tcf7 mCherry Rorc Thy1.1 FL at E11, E13, and E15. (E) Representative flow plots and histograms of bulk cultured Flt3 − Rorc − αLP, Rorc + αLP, iLTiP, and LTiP from Zbtb16 EGFPCre Tcf7 mCherry Rorc Thy1.1 E15 FL cultured for 2 d on OP9 stromal cells ( n = 3). Adjacent plot reflects CD4 + frequency among Rorc + Tcf7 + cells. (F) Single-cell potential of the indicated αLP precursors sorted from Zbtb16 EGFPCre Tcf7 mCherry Rorc Thy1.1 E15 FL onto OP9 stromal cells. (G) Hierarchical clustering dendrogram of ILC progenitor clonal potential on OP9 stromal cells calculated from Pearson correlation. For plots, each symbol represents an individual FL; data are presented as mean ± SEM; and P values were determined by one-way ANOVA with Tukey’s multiple comparisons test. P values for pie charts were calculated using Chi-Square Test for Independence followed by post-hoc analysis with Bonferroni correction; comparisons were made against the Flt3 + Rorc − αLP (black). Data are pooled from at least two independent experiments. **, P < 0.01; ***, P < 0.001; ****, P < 0.0001.

Article Snippet: The following fluorochrome- or biotin-conjugated antibodies were used: α4β7 (DATK32), CCR6 (29-2L17), CD11c (N418), CD19 (6D5), CD90.2 (Thy-1.2; 53–2.1), CD127 (IL-7Rα; A7R34), CXCR5 (L138D7), GR-1 (RB6-8C5), ICOS (C398.4A), PD-1 (29F.1A12), Ter119 (TER-119), mouse IgG1 κ-chain (MG1-45), mouse IgG2a κ-chain (MG2a-53), and rat IgG2b κ-chain (RTK45-30; all from BioLegend); B220 (RA3-6B2), CD3ε (145-2C11), CD4 (GK1.5), CD8α (53–6.7), CD11b (M1/70), Flt3 (A2F10.1), NK1.1 (PK136), TCRβ (H57-597), Thy1.1 (OX-7), RORγt (Q31-378), and PLZF (R17-809; all from BD Biosciences); TCF1 (Cell Signaling Technologies); and polyclonal goat α-Rb IgG (Abcam).

Techniques: Expressing, Flow Cytometry, Cell Culture

Effect of CR on the population of tumor-infiltrating lymphocytes (TILs). ( A ) Representative dot plots depicting (upper panels) or percentages (lower panel) of TILs expressing CD3 and CD45. B16-OVA-inoculated mice were treated with/without anti-PD-1 antibody (0.2 mg/mouse i.p.) at days 3, 6, and 9 from day 0. ( B ) Representative dot plots depicting (upper panels) or percentages (lower panel) of cells expressing CD4 and CD8 in the gated CD3 + CD45 + TILs. ( C ) Representative histograms representing surface expression (upper panels) or median fluorescence intensity (MFI) values (lower panel) of CD44 on CD3 + CD8 + CD45 + TILs derived from B16-OVA-inoculated mice. Each plot represents the mean ± SEM ( n = 4); indicated p values were obtained from a statistical comparison; one-way ANOVA with Bonferroni’s multiple comparisons correction.

Journal: Nutrients

Article Title: Calorie Restriction Impairs Anti-Tumor Immune Responses in an Immunogenic Preclinical Cancer Model

doi: 10.3390/nu15163638

Figure Lengend Snippet: Effect of CR on the population of tumor-infiltrating lymphocytes (TILs). ( A ) Representative dot plots depicting (upper panels) or percentages (lower panel) of TILs expressing CD3 and CD45. B16-OVA-inoculated mice were treated with/without anti-PD-1 antibody (0.2 mg/mouse i.p.) at days 3, 6, and 9 from day 0. ( B ) Representative dot plots depicting (upper panels) or percentages (lower panel) of cells expressing CD4 and CD8 in the gated CD3 + CD45 + TILs. ( C ) Representative histograms representing surface expression (upper panels) or median fluorescence intensity (MFI) values (lower panel) of CD44 on CD3 + CD8 + CD45 + TILs derived from B16-OVA-inoculated mice. Each plot represents the mean ± SEM ( n = 4); indicated p values were obtained from a statistical comparison; one-way ANOVA with Bonferroni’s multiple comparisons correction.

Article Snippet: The cells were then incubated with a saturating amount of fluorophore-conjugated antibodies against PE-Cy/7 CD45 (30-F11), FITC CD3ε (145-2C11), PerCP-Cy5.5 CD4 (GK1.5), APC CD8 (53-6.7), PE CD44 (IM7), APC-Cy7 CD62L (MEL-14) were purchased from Biolegend (San Diego, CA, USA).

Techniques: Expressing, Fluorescence, Derivative Assay, Comparison

T-MSCs inhibit DC-mediated T cell proliferation and differentiation of the CD4 + T cell subset. (a) T cells were isolated from mouse spleens (BALB/c, 8-week-old, female) using MACS. (b) T cells were cocultured with mature DCs in the presence or absence of T-MSCs, and differentiation into CD4 + T cell subsets was induced using anti-CD3 and anti-CD28 antibodies. T cell numbers were increased upon coculturing with mature DCs. In the presence of T-MSCs, however, T cell proliferation was inhibited by 80%. (c) Differentiation into Th1, Th2, and Th17 cells also was decreased upon addition of T-MSCs.

Journal: Stem Cells International

Article Title: Immune Suppressive Effects of Tonsil-Derived Mesenchymal Stem Cells on Mouse Bone-Marrow-Derived Dendritic Cells

doi: 10.1155/2015/106540

Figure Lengend Snippet: T-MSCs inhibit DC-mediated T cell proliferation and differentiation of the CD4 + T cell subset. (a) T cells were isolated from mouse spleens (BALB/c, 8-week-old, female) using MACS. (b) T cells were cocultured with mature DCs in the presence or absence of T-MSCs, and differentiation into CD4 + T cell subsets was induced using anti-CD3 and anti-CD28 antibodies. T cell numbers were increased upon coculturing with mature DCs. In the presence of T-MSCs, however, T cell proliferation was inhibited by 80%. (c) Differentiation into Th1, Th2, and Th17 cells also was decreased upon addition of T-MSCs.

Article Snippet: Separated cells were stained with PE-conjugated anti-mouse CD4 antibody (GK 1.5, Rat IgG 2b , BioLegend) and analyzed by flow cytometry to determine the purity of the cell population.

Techniques: Isolation

External beam radiation primes B78 tumor-bearing mice for BEMPEG treatment by increasing CD122 expression on CD8+ and CD4+ T-helper cells in the spleen; RT+BEMPEG increases the number of TILs in the B78 melanoma model. (A) Immune cell profile in the spleen 5 days after RT showing CD4+ T helpers/CD45+, CD4+ CD122+ T helpers/CD4+ T helpers, and CD122 MFI on CD4+ T helpers. (B) Immune cell profile in the spleen 5 days after RT showing CD8+/CD45+, CD8+ CD122+/CD8+, and CD122 MFI on CD8+T cells. A separate independent experiment (with a smaller sample size) demonstrated similar trends as the data presented in (A, B) (analyses here done by unpaired t-test). (C) The combined results from two independent flow experiments (n=5 per group, per experiment) showing the number of TILs as a ratio of live cells (or as a ratio to T regulatory cells for the last two panels) in the tumor following treatment with buffer (black), RT alone (blue), BEMPEG alone (pink), or RT+BEMPEG (purple) on day 14 after treatment began. Each symbol represents the TIL or splenic immune cell profile from one mouse (analyses done by one-way ANOVA). P values calculated using one-way ANOVA with Tukey’s multiple comparison tests. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001. For comparisons where there is no p value shown, the p value was not significant. ANOVA, analysis of variance; BEMPEG, bempegaldesleukin; RT, radiation therapy; TIL, tumor-infiltrating lymphocyte.

Journal: Journal for Immunotherapy of Cancer

Article Title: Combination of radiation therapy, bempegaldesleukin, and checkpoint blockade eradicates advanced solid tumors and metastases in mice

doi: 10.1136/jitc-2021-002715

Figure Lengend Snippet: External beam radiation primes B78 tumor-bearing mice for BEMPEG treatment by increasing CD122 expression on CD8+ and CD4+ T-helper cells in the spleen; RT+BEMPEG increases the number of TILs in the B78 melanoma model. (A) Immune cell profile in the spleen 5 days after RT showing CD4+ T helpers/CD45+, CD4+ CD122+ T helpers/CD4+ T helpers, and CD122 MFI on CD4+ T helpers. (B) Immune cell profile in the spleen 5 days after RT showing CD8+/CD45+, CD8+ CD122+/CD8+, and CD122 MFI on CD8+T cells. A separate independent experiment (with a smaller sample size) demonstrated similar trends as the data presented in (A, B) (analyses here done by unpaired t-test). (C) The combined results from two independent flow experiments (n=5 per group, per experiment) showing the number of TILs as a ratio of live cells (or as a ratio to T regulatory cells for the last two panels) in the tumor following treatment with buffer (black), RT alone (blue), BEMPEG alone (pink), or RT+BEMPEG (purple) on day 14 after treatment began. Each symbol represents the TIL or splenic immune cell profile from one mouse (analyses done by one-way ANOVA). P values calculated using one-way ANOVA with Tukey’s multiple comparison tests. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001. For comparisons where there is no p value shown, the p value was not significant. ANOVA, analysis of variance; BEMPEG, bempegaldesleukin; RT, radiation therapy; TIL, tumor-infiltrating lymphocyte.

Article Snippet: Cells were incubated with anti-CD16/32 (Biolegend, Clone 93) for 10 min at room temperature and then stained for 30 min at 4°C with the following antibodies: CD45 BV510 (30-F11), CD4 BV785 (GK1.5), CD8 APC-R700 (53–6.7), and NK1.1 PE-CF594 (PK136) all from BD Biosciences.

Techniques: Expressing